SCHEMBL30458073

SCHEMBL30458073

C=CCC(CCCCCCCCCCCCCCCC(=O)O)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC4 O15439 1/20 0.53
MAPT P10636 1/20 0.53
FOLH1 Q04609 5/20 0.50
GRIK1 P39086 2/20 0.47
GRIK2 Q13002 2/20 0.47
TSHR P16473 2/20 0.46
NFKB1 P19838 2/20 0.46
LMNA P02545 2/20 0.46
PMP22 Q01453 1/20 0.46
CPA1 P15085 1/20 0.46
GSTK1 Q9Y2Q3 1/20 0.44
FFAR4 Q5NUL3 1/20 0.43
FFAR1 O14842 1/20 0.43
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
BLM P54132 1/20 0.42
SLC6A3 Q01959 1/20 0.42
MEN1 O00255 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11802696 1.00 ABCC4 (0.53) ABCC4MAPTFOLH1GRIK1GRIK2
SCHEMBL11784979 1.00 ABCC4 (0.53) ABCC4MAPTFOLH1GRIK1GRIK2
SCHEMBL11796940 1.00 ABCC4 (0.53) ABCC4MAPTFOLH1GRIK1GRIK2
SCHEMBL11795592 0.98 ABCC4 (0.50) ABCC4MAPTFOLH1GRIK1GRIK2
SCHEMBL7752392 0.94 FOLH1 (0.52) ABCC4MAPTFOLH1GRIK1GRIK2
Hexanoate SCHEMBL31065019 0.86 AKR1B1 (0.53) MAPTTSHRLMNAFFAR4FFAR1
SCHEMBL463194 0.86 FOLH1 (0.56) FOLH1GRIK1GRIK2CPA1SLC6A2
SCHEMBL16041974 0.85 MAPT (0.53) ABCC4MAPTFOLH1GRIK1GRIK2
SCHEMBL11753937 0.85 MAPT (0.53) ABCC4MAPTFOLH1GRIK1GRIK2
SCHEMBL9014368 0.85 GRIK1 (0.47) ABCC4MAPTFOLH1GRIK1GRIK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260008761-A1 PROCESS FOR THE PREPARATION OF TAXANE DERIVATIVES INDENA S.P.A. (IT) 2026-01-08 US disclosed
EP-4408830-A1 PROCESS FOR THE PREPARATION OF TAXANE DERIVATIVES Indena S.p.A. (IT) 2024-08-07 EP disclosed
WO-2023053054-A1 PROCESS FOR THE PREPARATION OF TAXANE DERIVATIVES INDENA S.P.A. (IT) 2023-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008761-A1 PROCESS FOR THE PREPARATION OF TAXANE DERIVATIVES CBR1, OGFR, DHCR7 ABCC4 1055/4885MAPT 3982/4885FOLH1 1965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.